This paper describes the development of a mode choice model for the journey to work with special emphasis on the propensity to cycle. The model combines revealed preference (RP) and stated preference (SP) data to form a very large and comprehensive model. RP data from the National Travel Survey was combined with a specially commissioned RP survey.A number of SP surveys were also undertaken to examine the effects of different types of en-route and trip end cycle facilities and financial measures to encourage cycling. The development of the model is described in detail. The model was used to forecast trends in urban commuting shares over time and to predict the impacts of different measures to encourage cycling. Of the en-route cycle facilities, a completely segregated cycleway was forecast to have the greatest impact, but even the unfeasible scenario of universal provision of such facilities would only result in a 55% increase in cycling and a slight reduction in car commuting. Payments for cycling to work were found to be highly effective with a £2 daily payment almost doubling the level of cycling. The most effective policy would combine improvements in en-route facilities, a daily payment to cycle to work and comprehensive trip end facilities and this would also have a significant impact on car commuting.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document. When citing, please reference the published version. Take down policy While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been uploaded in error or has been deemed to be commercially or otherwise sensitive.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.